Mapping of somatostatin receptor types in GH or/and PRL producing pituitary adenomas

Journal of Clinical Pathology
E ThodouM Pateraki

Abstract

Somatostatin is a tetradecapeptide exerting inhibitory action on endocrine and exocrine cell secretion and proliferation. Somatostatin receptors (SST) are widely expressed in various neoplasms including endocrine tumours. Using immunohistochemistry, the expression of SST(1), SST(2A), SST(2B), SST(3), SST(4), and SST(5) was studied in tissue microarrays (TMAs), using a series of 90 human pituitary adenomas producing growth hormone and/or prolactin, including 30 of each somatotroph, lactotroph, and mixed somatotroph/lactotroph adenoma type. For immunohistochemistry, the standard avidin biotin complex method enhanced by tyramide was used, using polyclonal antisera for all SST types. A four point scoring system was used to assess the membranous immunopositivity. All SST types were positive in all tumour types, showing varying immunoreactivity scores. SST(5) and SST(2A) were the predominant receptors, showing strong expression in high frequency in all three adenoma types. Strong expression of SST(1) was higher in lactotroph adenomas than in other tumour types. The immunohistochemical results of SST expression are in agreement with most findings of previous molecular studies. The fact that SST(2A) expression is predominant suggests t...Continue Reading

References

Dec 1, 1987·The Journal of Clinical Endocrinology and Metabolism·J C ReubiS W Lamberts
Dec 15, 1983·The New England Journal of Medicine·S Reichlin
Apr 1, 1995·The Journal of Clinical Endocrinology and Metabolism·G M MillerA Klibanski
Feb 1, 1994·The Journal of Clinical Endocrinology and Metabolism·Y Greenman, S Melmed
Aug 1, 1995·Endocrine Reviews·T Reisine, G I Bell
Jul 14, 1998·The Journal of Clinical Endocrinology and Metabolism·E MatoA De Leiva
Jul 14, 1998·Nature Medicine·J KononenO P Kallioniemi
Jul 17, 1998·The American Journal of Pathology·J C ReubiA Schonbrunn
Aug 26, 1998·The Journal of Clinical Endocrinology and Metabolism·S NielsenJ O Jørgensen
Feb 18, 1999·The Journal of Clinical Endocrinology and Metabolism·L J HoflandS W Lamberts
Aug 6, 1999·Frontiers in Neuroendocrinology·Y C Patel
Sep 16, 1999·The Journal of Clinical Endocrinology and Metabolism·P JaquetA Enjalbert
Mar 14, 2000·The Journal of Biological Chemistry·M RochevilleY C Patel
Mar 16, 2000·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·M PapottiG Bussolati
Aug 2, 2001·Journal of the National Cancer Institute·R SimonG Sauter
Feb 18, 2003·Endocrine Reviews·Leo J Hofland, Steven W J Lamberts
Aug 16, 2003·Endocrine Reviews·Jean Claude Reubi
Apr 9, 2004·The Journal of Clinical Endocrinology and Metabolism·Leo J HoflandSteven W J Lamberts

❮ Previous
Next ❯

Citations

Jun 1, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Daniel KaemmererRichard Paul Baum
Oct 19, 2006·Neuroendocrinology·George Kontogeorgos
Oct 27, 2009·Drugs·Richard A FeeldersAart-Jan van der Lely
Oct 5, 2010·Neurosurgical Focus·Sunil ManjilaWarren R Selman
Jun 7, 2013·Expert Opinion on Pharmacotherapy·Alexander Faje, Lisa Nachtigall
Feb 5, 2008·Molecular and Cellular Endocrinology·A SaveanuA Barlier
Jan 4, 2015·Annales d'endocrinologie·Thomas CunyFederico Gatto
Aug 25, 2017·The Journal of Endocrinology·Alejandro Ibáñez-Costa, Márta Korbonits
Oct 20, 2018·Nuclear Medicine Communications·Vladimir R VukomanovicAleksandar Djukic
Jan 17, 2008·The Journal of Clinical Endocrinology and Metabolism·Ursula PlöckingerStefan Schulz
Apr 24, 2017·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Benxia YuMiao Xu
Sep 16, 2017·The Journal of Clinical Endocrinology and Metabolism·Kristin Astrid ØysteseJens Bollerslev
Oct 16, 2018·Annales d'endocrinologie·Hélène LasolleGerald Raverot

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.